High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation

Toru Nishi, Kimio Yoshizato, Shigeo Yamashiro, Hideo Takeshima, Kyoichi Sato, Kazuya Hamada, Isao Kitamura, Teizo Yoshimura, Hideyuki Saya, Jun Ichi Kuratsu, Yukitaka Ushio

Research output: Contribution to journalArticle

252 Citations (Scopus)

Abstract

A novel method for high-efficiency and region-controlled in vivo gene transfer was developed by combining in vivo electroporation and intraarterial plasmid DNA injection. A mammalian expression plasmid for the Escherichia coli lacZ gene (driven with a SV40 early promoter) was injected into the internal carotid artery of rats whose brain tumors (from prior inoculation) had been electroporated between two electrodes. The lacZ gene was efficiently transferred and expressed in the tumor cells 3 days after plasmid injection. However, neither any gene transfers nor any elevated lacZ activity was detected in tissues outside the electrodes. The plasmid was not transferred without electroporation. Human monocyte chemoattractant protein-1 cDNA was also transferred by this method, and its long-lasting (3 weeks) expression was confirmed by using the Epstein-Barr virus episomal replicon system. The expressed monocyte chemoattractant protein-1 protein was functional, as evident by the presence of a large number of monocytes in the tumor tissue. This method, 'electrogene therapy,' which does not require viral genes or particles, allows genes to be transferred and expressed in desired organs or tissues, and it may lead to the development of a new type of highly effective gene therapy.

Original languageEnglish
Pages (from-to)1050-1055
Number of pages6
JournalCancer Research
Volume56
Issue number5
Publication statusPublished - Mar 1 1996
Externally publishedYes

Fingerprint

Electroporation
Plasmids
Injections
Lac Operon
DNA
Genes
Electrodes
Replicon
Viral Genes
Chemokine CCL2
Internal Carotid Artery
Human Herpesvirus 4
Brain Neoplasms
Genetic Therapy
Virion
Monocytes
Neoplasms
Complementary DNA
Escherichia coli
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Nishi, T., Yoshizato, K., Yamashiro, S., Takeshima, H., Sato, K., Hamada, K., ... Ushio, Y. (1996). High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Research, 56(5), 1050-1055.

High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. / Nishi, Toru; Yoshizato, Kimio; Yamashiro, Shigeo; Takeshima, Hideo; Sato, Kyoichi; Hamada, Kazuya; Kitamura, Isao; Yoshimura, Teizo; Saya, Hideyuki; Kuratsu, Jun Ichi; Ushio, Yukitaka.

In: Cancer Research, Vol. 56, No. 5, 01.03.1996, p. 1050-1055.

Research output: Contribution to journalArticle

Nishi, T, Yoshizato, K, Yamashiro, S, Takeshima, H, Sato, K, Hamada, K, Kitamura, I, Yoshimura, T, Saya, H, Kuratsu, JI & Ushio, Y 1996, 'High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation', Cancer Research, vol. 56, no. 5, pp. 1050-1055.
Nishi T, Yoshizato K, Yamashiro S, Takeshima H, Sato K, Hamada K et al. High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Research. 1996 Mar 1;56(5):1050-1055.
Nishi, Toru ; Yoshizato, Kimio ; Yamashiro, Shigeo ; Takeshima, Hideo ; Sato, Kyoichi ; Hamada, Kazuya ; Kitamura, Isao ; Yoshimura, Teizo ; Saya, Hideyuki ; Kuratsu, Jun Ichi ; Ushio, Yukitaka. / High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. In: Cancer Research. 1996 ; Vol. 56, No. 5. pp. 1050-1055.
@article{0bde50f244984c5c9aa0d905c8eb2ea0,
title = "High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation",
abstract = "A novel method for high-efficiency and region-controlled in vivo gene transfer was developed by combining in vivo electroporation and intraarterial plasmid DNA injection. A mammalian expression plasmid for the Escherichia coli lacZ gene (driven with a SV40 early promoter) was injected into the internal carotid artery of rats whose brain tumors (from prior inoculation) had been electroporated between two electrodes. The lacZ gene was efficiently transferred and expressed in the tumor cells 3 days after plasmid injection. However, neither any gene transfers nor any elevated lacZ activity was detected in tissues outside the electrodes. The plasmid was not transferred without electroporation. Human monocyte chemoattractant protein-1 cDNA was also transferred by this method, and its long-lasting (3 weeks) expression was confirmed by using the Epstein-Barr virus episomal replicon system. The expressed monocyte chemoattractant protein-1 protein was functional, as evident by the presence of a large number of monocytes in the tumor tissue. This method, 'electrogene therapy,' which does not require viral genes or particles, allows genes to be transferred and expressed in desired organs or tissues, and it may lead to the development of a new type of highly effective gene therapy.",
author = "Toru Nishi and Kimio Yoshizato and Shigeo Yamashiro and Hideo Takeshima and Kyoichi Sato and Kazuya Hamada and Isao Kitamura and Teizo Yoshimura and Hideyuki Saya and Kuratsu, {Jun Ichi} and Yukitaka Ushio",
year = "1996",
month = "3",
day = "1",
language = "English",
volume = "56",
pages = "1050--1055",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation

AU - Nishi, Toru

AU - Yoshizato, Kimio

AU - Yamashiro, Shigeo

AU - Takeshima, Hideo

AU - Sato, Kyoichi

AU - Hamada, Kazuya

AU - Kitamura, Isao

AU - Yoshimura, Teizo

AU - Saya, Hideyuki

AU - Kuratsu, Jun Ichi

AU - Ushio, Yukitaka

PY - 1996/3/1

Y1 - 1996/3/1

N2 - A novel method for high-efficiency and region-controlled in vivo gene transfer was developed by combining in vivo electroporation and intraarterial plasmid DNA injection. A mammalian expression plasmid for the Escherichia coli lacZ gene (driven with a SV40 early promoter) was injected into the internal carotid artery of rats whose brain tumors (from prior inoculation) had been electroporated between two electrodes. The lacZ gene was efficiently transferred and expressed in the tumor cells 3 days after plasmid injection. However, neither any gene transfers nor any elevated lacZ activity was detected in tissues outside the electrodes. The plasmid was not transferred without electroporation. Human monocyte chemoattractant protein-1 cDNA was also transferred by this method, and its long-lasting (3 weeks) expression was confirmed by using the Epstein-Barr virus episomal replicon system. The expressed monocyte chemoattractant protein-1 protein was functional, as evident by the presence of a large number of monocytes in the tumor tissue. This method, 'electrogene therapy,' which does not require viral genes or particles, allows genes to be transferred and expressed in desired organs or tissues, and it may lead to the development of a new type of highly effective gene therapy.

AB - A novel method for high-efficiency and region-controlled in vivo gene transfer was developed by combining in vivo electroporation and intraarterial plasmid DNA injection. A mammalian expression plasmid for the Escherichia coli lacZ gene (driven with a SV40 early promoter) was injected into the internal carotid artery of rats whose brain tumors (from prior inoculation) had been electroporated between two electrodes. The lacZ gene was efficiently transferred and expressed in the tumor cells 3 days after plasmid injection. However, neither any gene transfers nor any elevated lacZ activity was detected in tissues outside the electrodes. The plasmid was not transferred without electroporation. Human monocyte chemoattractant protein-1 cDNA was also transferred by this method, and its long-lasting (3 weeks) expression was confirmed by using the Epstein-Barr virus episomal replicon system. The expressed monocyte chemoattractant protein-1 protein was functional, as evident by the presence of a large number of monocytes in the tumor tissue. This method, 'electrogene therapy,' which does not require viral genes or particles, allows genes to be transferred and expressed in desired organs or tissues, and it may lead to the development of a new type of highly effective gene therapy.

UR - http://www.scopus.com/inward/record.url?scp=9044230116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9044230116&partnerID=8YFLogxK

M3 - Article

C2 - 8640760

AN - SCOPUS:9044230116

VL - 56

SP - 1050

EP - 1055

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 5

ER -